HSPA5 repressed ferroptosis to promote CRC development by maintaining GPX4 stability, which slowed GPX4 degradation to give CRC cells more time to adjust to erastin toxicity [40]. The gene discussed is HSPA5; the disease is colorectal carcinoma.